← Every company
Axsome Therapeutics Inc Executive Compensation
What Axsome Therapeutics Inc's board awarded its chief executive, and what the same award was worth once the share price had moved. Companies have had to disclose both since 2023, and they routinely differ by several times over.
AXSM on carbonthat →Latest year
2025
5 years disclosed
Awarded that year
$10.3M
Actually paid
$33.8M
after revaluation
Across every year
$46.9M
$70.4M actually paid
Year by year
Newest first. A negative figure means the award lost more than its whole value over the year.
| Year | Awarded | Actually paid |
|---|---|---|
| 20253.3×$100 → $224 | $10.3M | $33.8M |
| 20241.0×$100 → $104 | $10.4M | $10.1M |
| 20231.0×$100 → $98 | $9.9M | $9.6M |
| 20223.4×$100 → $95 | $8.3M | $28M |
| 2021-1.4×$100 → $46 | $8.1M | -$11.1M |
Source: pay-versus-performance disclosures, read from SEC XBRL company facts. "Compensation actually paid" is a revaluation of awards that may never vest, not cash received — a board that awards shares and watches them halve discloses the second, smaller figure, and that is the disclosure working rather than a pay cut. Only the years a company tagged where the SEC's data can reach them appear here.
More on AXSM
Company overviewEverything on AXSM in one place, with the price.SEC filingsWhat AXSM's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat AXSM's own officers and directors buy and sell.Who owns itEvery manager reporting a position in AXSM.Funds holding itWhich funds and ETFs hold AXSM, and how big a bet.PatentsWhat AXSM is filing at the patent office.